150 related articles for article (PubMed ID: 22465890)
1. Erythropoietin for acute multiple sclerosis in patients with optic neuritis as a first demyelination event.
Borhani-Haghighi A; Ghodsi M; Razeghinejad MR; Mardani S; Mardani M; Nikseresht AR; Safari A; Bagheri MH
Neurosciences (Riyadh); 2012 Apr; 17(2):151-5. PubMed ID: 22465890
[TBL] [Abstract][Full Text] [Related]
2. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.
Beck RW; Cleary PA; Trobe JD; Kaufman DI; Kupersmith MJ; Paty DW; Brown CH
N Engl J Med; 1993 Dec; 329(24):1764-9. PubMed ID: 8232485
[TBL] [Abstract][Full Text] [Related]
3. Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial.
Leist TP; Comi G; Cree BA; Coyle PK; Freedman MS; Hartung HP; Vermersch P; Casset-Semanaz F; Scaramozza M;
Lancet Neurol; 2014 Mar; 13(3):257-67. PubMed ID: 24502830
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis.
Sühs KW; Hein K; Sättler MB; Görlitz A; Ciupka C; Scholz K; Käsmann-Kellner B; Papanagiotou P; Schäffler N; Restemeyer C; Bittersohl D; Hassenstein A; Seitz B; Reith W; Fassbender K; Hilgers R; Heesen C; Bähr M; Diem R
Ann Neurol; 2012 Aug; 72(2):199-210. PubMed ID: 22926853
[TBL] [Abstract][Full Text] [Related]
5. Acute inflammatory demyelinating optic neuritis: current concepts in diagnosis and management.
Bhatti MT; Schmitt NJ; Beatty RL
Optometry; 2005 Sep; 76(9):526-35. PubMed ID: 16198993
[TBL] [Abstract][Full Text] [Related]
6. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group.
Jacobs LD; Beck RW; Simon JH; Kinkel RP; Brownscheidle CM; Murray TJ; Simonian NA; Slasor PJ; Sandrock AW
N Engl J Med; 2000 Sep; 343(13):898-904. PubMed ID: 11006365
[TBL] [Abstract][Full Text] [Related]
7. Long-term brain magnetic resonance imaging changes after optic neuritis in patients without clinically definite multiple sclerosis.
Optic Neuritis Study Group
Arch Neurol; 2004 Oct; 61(10):1538-41. PubMed ID: 15477507
[TBL] [Abstract][Full Text] [Related]
8. Pediatric optic neuritis: brain MRI abnormalities and risk of multiple sclerosis.
Bonhomme GR; Waldman AT; Balcer LJ; Daniels AB; Tennekoon GI; Forman S; Galetta SL; Liu GT
Neurology; 2009 Mar; 72(10):881-5. PubMed ID: 19273821
[TBL] [Abstract][Full Text] [Related]
9. Multifocal visual evoked potential analysis of inflammatory or demyelinating optic neuritis.
Fraser CL; Klistorner A; Graham SL; Garrick R; Billson FA; Grigg JR
Ophthalmology; 2006 Feb; 113(2):323.e1-323.e2. PubMed ID: 16406544
[TBL] [Abstract][Full Text] [Related]
10. Effect of early interferon beta-1a therapy on conversion to multiple sclerosis in Iranian patients with a first demyelinating event.
Pakdaman H; Sahraian MA; Fallah A; Pakdaman R; Ghareghozli K; Ghafarpour M; Rahimian E; Shirani A
Acta Neurol Scand; 2007 Jun; 115(6):429-31. PubMed ID: 17511854
[TBL] [Abstract][Full Text] [Related]
11. Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis: a randomized, double-blind, placebo-controlled trial.
Achiron A; Kishner I; Sarova-Pinhas I; Raz H; Faibel M; Stern Y; Lavie M; Gurevich M; Dolev M; Magalashvili D; Barak Y
Arch Neurol; 2004 Oct; 61(10):1515-20. PubMed ID: 15477504
[TBL] [Abstract][Full Text] [Related]
12. Disease Activity and Conversion into Multiple Sclerosis after Optic Neuritis Is Treated with Erythropoietin.
Sühs KW; Papanagiotou P; Hein K; Pul R; Scholz K; Heesen C; Diem R
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27706045
[TBL] [Abstract][Full Text] [Related]
13. Predictive role of evoked potential examinations in patients with clinically isolated optic neuritis in light of the revised McDonald criteria.
Simó M; Barsi P; Arányi Z
Mult Scler; 2008 May; 14(4):472-8. PubMed ID: 18208873
[TBL] [Abstract][Full Text] [Related]
14. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients.
Lebrun C; Bensa C; Debouverie M; Wiertlevski S; Brassat D; de Seze J; Rumbach L; Pelletier J; Labauge P; Brochet B; Tourbah A; Clavelou P;
Arch Neurol; 2009 Jul; 66(7):841-6. PubMed ID: 19597085
[TBL] [Abstract][Full Text] [Related]
15. Early MRI in optic neuritis: the risk for clinically definite multiple sclerosis.
Swanton JK; Fernando KT; Dalton CM; Miszkiel KA; Altmann DR; Plant GT; Thompson AJ; Miller DH
Mult Scler; 2010 Feb; 16(2):156-65. PubMed ID: 20086028
[TBL] [Abstract][Full Text] [Related]
16. Risk of multiple sclerosis after optic neuritis in patients with normal baseline brain MRI.
Marques IB; Matias F; Silva ED; Cunha L; Sousa L
J Clin Neurosci; 2014 Apr; 21(4):583-6. PubMed ID: 24231563
[TBL] [Abstract][Full Text] [Related]
17. Acute inflammatory demyelinating optic neuritis: evidence-based visual and neurological considerations.
Abou Zeid N; Bhatti MT
Neurologist; 2008 Jul; 14(4):207-23. PubMed ID: 18617847
[TBL] [Abstract][Full Text] [Related]
18. Preventive effect of vitamin D3 supplementation on conversion of optic neuritis to clinically definite multiple sclerosis: a double blind, randomized, placebo-controlled pilot clinical trial.
Derakhshandi H; Etemadifar M; Feizi A; Abtahi SH; Minagar A; Abtahi MA; Abtahi ZA; Dehghani A; Sajjadi S; Tabrizi N
Acta Neurol Belg; 2013 Sep; 113(3):257-63. PubMed ID: 23250818
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, placebo-controlled trial of adding erythropoietin to intravenous methylprednisolone for the treatment of unilateral acute optic neuritis of unknown or demyelinative origin.
Shayegannejad V; Shahzamani S; Dehghani A; Dast Borhan Z; Rahimi M; Mirmohammadsadeghi A
Graefes Arch Clin Exp Ophthalmol; 2015 May; 253(5):797-801. PubMed ID: 25605544
[TBL] [Abstract][Full Text] [Related]
20. MRI in the diagnosis of pediatric multiple sclerosis.
Callen DJ; Shroff MM; Branson HM; Lotze T; Li DK; Stephens D; Banwell BL
Neurology; 2009 Mar; 72(11):961-7. PubMed ID: 19038852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
